Can-Fite BioPharma Progresses Through Clinical Trials: Completed Enrollment Of Half The Patients Required For Phase IIb RA Trial And Is Scheduled To Receive Next Payment Fom The Japanese Seikagaku Corporation
Can-Fite Progresses Through Clinical Trials: Completed Enrollment of Half the Patients Required for Phase IIb RA Trial and is Scheduled to Receive Next Payment from the Japanese Seikagaku Corporation